Table 1 Clinical characteristics of patients.

From: Rapid, quantitative, and high-sensitivity detection of anti-phospholipase A2 receptor antibodies using a novel CdSe/ZnS-based fluorescence immunosorbent assay

 

Normal range

All patients (n = 135)

IMN (n = 68)

Non-IMN (n = 67)

P-value

Age (years)

 

48 (36–57)

49.5 (41.5–56)

47 (32–58)

0.28

Sex (female/male)

 

62/73

27/41

35/32

0.144

Serum total protein (g/L)

58–80

54.62 (46.25–61.65)

50.21 (43.42–57.71)

58.63 (50.41–65.54)

< 0.001

Serum albumin (g/L)

38–60

29.91(22.20–34.93)

28 (21.31–32.46)

33.24 (25.30–36.38)

0.003

24-h proteinuria (g/24 h)

0–0.25

3.26 (1.89–7.68)

5.29 (2.64–9.41)

2.32 (0.88–4.08)

< 0.001

Serum creatinine (μmol/L)

44–88

72.82 (53.67–93.38)

69.83 (52.56–88.01)

75.58 (58.52–105.52)

0.073

eGFR (ml/min per 1.73 m2)

≥ 90

102.82 (69.55–129.04)

106.1 (85.89–136.34)

96.57 (55.83–125.42)

0.028

Urea (mmol/L)

2.3–7

5.26 (4.16–7.44)

4.93 (3.72–7.03)

5.41 (4.28–8.05)

0.159

Cystatin C (mg/L)

0.65–1.09

1.17 (0.91–1.51)

1.07 (0.85–1.33)

1.22 (0.97–1.7)

0.024

  1. Continuous variables are presented as median (interquartile ranges).
  2. IMN idiopathic membranous nephropathy, eGFR estimated glomerular filtration rate.
Back to article page